Clinical investigation of medicinal products for the treatment and prevention of bipolar disorder

  • Email
  • Help
Current effective version

Adopted guideline

Currently under revision - see below

Reference numberCPMP/EWP/567/1998
Effective from01/10/2001
KeywordsBipolar disorder, clinical investigation
DescriptionThis document provides guidance on the evaluation of new medicinal products intended for the use in the treatment of bipolar disorder.

Document history

Revision 1

In progress

Concept paper

Published: 28/07/2016

Deadline for comments: 31/10/2016


First version

Current version

Adopted guideline

In operation: 01/10/2001–present

Related content

How helpful is this page?

Average rating:

 Based on 21 ratings

Add your rating:

See all ratings
4 ratings
4 ratings
4 ratings
4 ratings
5 ratings

Tell us more